BioSpace News Archive

Business

Four Fresh-Faced Biopharmas Reel in Millions in Series A Funds

The cash came rolling in for four biopharma companies Thursday morning, with collective Series A rounds totaling more than $125 million.

December 9, 2021
·
3 min read
·
Vanessa Doctor, RN
Career Advice

Signs That You Should or Shouldn’t Switch Your Job

Deciding on when to switch your job can be a difficult decision to make.

December 9, 2021
·
2 min read
·
Brandi Marcene
Career Advice

Tips and Tricks to Enhance Your LinkedIn Profile

Instead of letting LinkedIn slide to the bottom of your to-do list day after day, dedicate some time to it. Here’s what you need to add to your LinkedIn post.

December 9, 2021
·
4 min read
·
Hannah Harshman
Drug Development

New Study: Fat Cells Are a Reservoir for COVID-19 Infection

Researchers published a study proving that SARS-CoV-2 infects human adipose or fat tissue to multiply and elicit an inflammatory response corresponding with severe COVID-19.

December 9, 2021
·
2 min read
·
Kate Goodwin
Drug Development

EUA of AstraZeneca’s Pre-Exposure Therapy Offers Hope for Immunocompromised

The FDA has approved emergency use authorization for AstraZeneca’s Evusheld cocktail as prophylaxis against COVID-19 infection in adults and adolescents aged at least 12 years.

December 9, 2021
·
2 min read
·
Vanessa Doctor, RN
FDA

Reata Stock Takes a Blow as FDA Panel Voted Down Alport Syndrome Drug

Shares of Reata Pharmaceuticals have plunged nearly 40% in premarket trading after an FDA advisory panel recommended against the approval of its Alport syndrome disease treatment, bardoxolone.

December 9, 2021
·
2 min read
·
Alex Keown
Business

BioSpace Movers & Shakers, Dec. 10

As the year comes to an end, biopharma and life sciences companies are strengthening their leadership teams and boards with the latest round of Movers & Shakers.

December 9, 2021
·
8 min read
·
Alex Keown
Business

1E Therapeutics Raises $120 Million in Seed Funding

1E Therapeutics announced $120 million seed funding, a remarkable feat for an early-stage biotech company. The funding is the largest of its kind for an Israeli biotech company.

December 9, 2021
·
2 min read
·
Alvin Clavines
CSL and uniQure’s Hemophilia B Gene Therapy Hits the Mark

CSL Behring and uniQure announced that their etranacogene dezaparvovec hit the pre-specified primary endpoint in their Phase III clinical trial in severe to moderately severe hemophilia B.

December 9, 2021
·
3 min read
·
Mark Terry
Drug Development

China Puts Renewed Focus on Monoclonal Antibodies in COVID-19 Fight

Researchers in China are busy developing several treatments, combining vaccines and drugs for COVID-19, and also working on monoclonal antibodies treatment.

December 9, 2021
·
8 min read
·
BioSpace Editorial Staff